Target intelligence / Profile preview

Outer dense fiber protein 2 (ODF2)

Target
ODF2
Molecular classification
Other (Sperm tail cytoskeletal protein), Centrosome scaffold protein
01

Overview

Outer dense fiber protein 2 (ODF2) is a major structural protein in the outer dense fibers of sperm tails and is essential for sperm tail elasticity, structural integrity, and protection from shear forces during sperm transport[1][3][5][7]. ODF2 also serves critical roles in somatic cells as a component of centrosomal appendages—especially at the mother centriole—where it helps create the scaffold for microtubule organization and contributes to cell cycle–dependent centriole maturation[1][3][7]. Mutations in ODF2 can cause severe sperm abnormalities and infertility by disrupting the physical stability of the sperm head-tail connection or the flagellar structure[5][7]. Alternative splicing results in isoforms known as "cenexins" that selectively localize to somatic centrioles, further defining its role in centrosome biology[7]. ODF2 has also been classified as a cancer/testis antigen (CT134), meaning it is expressed in the testis and abnormally in some cancers, offering potential (though still exploratory) relevance as a tumor biomarker[6][7]. No known therapeutic drugs directly target ODF2 or use it as a validated drug target.

Other names
Outer dense fiber protein 2ODF84CT134Cenexincancer/testis antigen 134cenexin 1sperm tail structural proteintestis tissue sperm-binding protein Li 51eouter dense fiber of sperm tails protein 2
02

Biological functions

Sperm tail structure and elasticityProtection of flagella from shear stressScaffold formation at centrosomes (centriole appendages, especially mother centriole)Microtubule organizing center formation
03

Disease associations

Infertility (specifically spermatogenic failure)Potential cancer/testis antigen (cancer biomarker, epithelial and some other cancers)
04

Safety considerations

Mutation or haploinsufficiency linked to male infertility (decapitated/decadent spermatozoa)No known systemic therapeutic safety concerns as no targeted drugs exist
05

Biomarkers

Biomarker for certain cases of male infertility (especially decapitated and decaudated spermatozoa)Cancer/testis antigen (possible cancer biomarker, though not broadly validated for therapy)

Beyond the preview

Go deeper on Outer dense fiber protein 2 (ODF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer dense fiber protein 2 (ODF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call